healthcare providers

Superior Processing System

Over 28,000 caregivers have collected cord blood for Cord Blood Registry in over 3,500 hospitals located in all 50 states and more than 70 countries.

As a CBR provider, you can connect to the latest cord blood information, including patient status, education tracking, collection statistics, and much more.

> Get Connected Now

Superior Processing System

CBR's CellAdvantage® cord blood processing system uses automation technology developed by ThermoGenesis™ and distributed by GE Healthcare®. The technology, called the AXP AutoXpress™ Platform (AXP™), is the industry's first functionally-closed, automated cord blood stem cell processing technology. Using this system, CBR anticipates meeting and exceeding its current cell recovery rate of 99 percent, which is the highest published cell recovery rate in the industry.

Full Cell Separation - For the Best Transplant Results

Cord Blood Registry's unique cell separation methods improve the viability and usability of samples when compared to other methods of cell processing. Our methods were thoroughly researched before storing samples for our clients and have been continually improved over the last decade. CBR's lab director, Dr. David T. Harris, has published data regarding our processing methods and results in several medical journals. Our published results show that our methods routinely recover more than 99 percent of the original mononuclear cell population. CBR's lab has over ten years of experience performing this highly specialized procedure for thousands of clients - an achievement unrivaled in this industry.

Click here to learn about our secure storage facilty.

ThermoGenesis©,Autoxpress™ , and AXP™ are registered trademarks of ThermoGenisis Corp., Sepax is a registered trademark of Biosafe SA. Viacord is a registered trademark of ViaCell,Inc

Banking cord blood does not guarantee that the cells will provide a cure or be applicable for every situation. For inherited genetic conditions, the child will not be able to use his or her own stem cells. A matched sibling's stem cells would be the first choice. Ultimate use will be determined by the treating physician. Treatment for brain injury and juvenile diabetes is experimental and currently requires the use of your own cord blood. Medical treatments using family banked cord tissue are in early research and are not available today; there is no guarantee that therapies will be developed in the future.
Share this page with family and friends: